{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:17:23Z","timestamp":1777317443776,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe University","doi-asserted-by":"publisher","award":["THD-2024-21502"],"award-info":[{"award-number":["THD-2024-21502"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xphs.2025.104064","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:29:46Z","timestamp":1763537386000},"page":"104064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"115","author":[{"given":"Damla","family":"Gungor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0798-5705","authenticated-orcid":false,"given":"Semsi","family":"Muratoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eren","family":"Aytekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba","family":"Re\u00e7ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokcen","family":"Telli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yagmur","family":"Akdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugba","family":"Gulsun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","article-title":"Pathophysiology of diabetes: an overview","volume":"10","author":"Banday","year":"2020","journal-title":"Avicenna J Med"},{"key":"10.1016\/j.xphs.2025.104064_bib0002","first-page":"224","article-title":"Diabetes Mellitus: A review","volume":"3","author":"Deshmukh","year":"2015","journal-title":"Int J Pure Appl Biosci"},{"issue":"5","key":"10.1016\/j.xphs.2025.104064_bib0003","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Suppl 2","key":"10.1016\/j.xphs.2025.104064_bib0004","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.3233\/JAD-2011-111127","article-title":"Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin","volume":"30","author":"Moreira","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.xphs.2025.104064_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.xphs.2025.104064_bib0006","article-title":"Alzheimer\u2019s disease: drug discovery","author":"Huang","year":"2020","journal-title":"Avustralya: Exon"},{"key":"10.1016\/j.xphs.2025.104064_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102383","article-title":"True or false? Alzheimer's disease is type 3 diabetes: evidences from bench to bedside","volume":"99","author":"Peng","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.xphs.2025.104064_bib0008","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-170440","article-title":"Comorbidity analysis between Alzheimer's disease and type 2 diabetes mellitus (T2DM) based on shared pathways and the role of T2DM drugs","volume":"60","author":"Karki","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.xphs.2025.104064_bib0009","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","article-title":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities","volume":"2","author":"Patrone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.xphs.2025.104064_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s007020200028","article-title":"The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update","volume":"109","author":"Hoyer","year":"2002","journal-title":"J Neural Transm"},{"issue":"10","key":"10.1016\/j.xphs.2025.104064_bib0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nature Reviews Neurology"},{"issue":"9","key":"10.1016\/j.xphs.2025.104064_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093165","article-title":"Type 3 diabetes and its role implications in Alzheimer's disease","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104064_bib0013","first-page":"95","article-title":"Oral antidiyabetik ila\u00e7lar","volume":"8","author":"\u00c7ubuk","year":"2015","journal-title":"Kocatepe Vet J"},{"issue":"6","key":"10.1016\/j.xphs.2025.104064_bib0014","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/17425255.2016.1187131","article-title":"Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus","volume":"12","author":"Malek","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.xphs.2025.104064_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"Antidiabetic drugs restore abnormal transport of amyloid-beta across the blood-brain barrier and memory impairment in db\/db mice","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xphs.2025.104064_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100936","article-title":"Diabetes drugs in the fight against Alzheimer's disease","volume":"54","author":"Boccardi","year":"2019","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215989","article-title":"Correction: systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents","volume":"14","author":"Lahmann","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040269","article-title":"Blood-brain delivery methods using nanotechnology","volume":"10","author":"Teleanu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.104064_bib0019","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijpharm.2017.07.030","article-title":"Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion","volume":"529","author":"Abdou","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.104064_bib0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molliq.2018.01.123","article-title":"Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation","volume":"255","author":"Haider","year":"2018","journal-title":"J Mol Liq"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.104064_bib0021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2014.10.044","article-title":"Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation","volume":"477","author":"Hong","year":"2014","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.104064_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2017.12.005","article-title":"Drug nanocrystals - versatile option for formulation of poorly soluble materials","volume":"537","author":"Peltonen","year":"2018","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2025.104064_bib0023","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.xphs.2021.10.004","article-title":"Development of fully redispersible dried nanocrystals by using sucrose laurate as stabilizer for increasing surface area and dissolution rate of poorly water-soluble drugs","volume":"111","author":"Prajapati","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104064_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103951","article-title":"Tumor-targeted nano-delivery system of camptothecin nanocrystals for the effective treatment of triple negative breast cancer","author":"Zhao","year":"2025","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2025.104064_bib0025","first-page":"2482","article-title":"Preparation and characterization of rivaroxaban nanocrystals prepared by combination of wet ball milling and high pressure homogenization methods","volume":"37","author":"Demir","year":"2018","journal-title":"Lat Am J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2025.104064_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/0113816128321501240828054050","article-title":"Optimization of glyburide-loaded nanosuspensions via ball milling and homogenization techniques: A Central composite design approach for enhanced solubility","volume":"31","author":"Gungor","year":"2025","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.xphs.2025.104064_bib0027","unstructured":"The European Pharmacopoeia 10th Edition, European Directorate for the Quality of Medicines & HealthCare 10 ed: European Directorate for the Quality of Medicines & HealthCare."},{"key":"10.1016\/j.xphs.2025.104064_bib0028","series-title":"Glyburide Monograph","first-page":"2236","article-title":"United States Pharmacopeia 30-NF 25","year":"2005"},{"issue":"8","key":"10.1016\/j.xphs.2025.104064_bib0029","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/10837450.2020.1772290","article-title":"Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets","volume":"25","author":"Gulsun","year":"2020","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2025.104064_bib0030","series-title":"The United States Pharmacopeial Convention","article-title":"Glyburide tablets monograph","year":"2010"},{"issue":"10","key":"10.1016\/j.xphs.2025.104064_bib0031","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/bmc.635","volume":"20","author":"Venkatesh","year":"2006","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.xphs.2025.104064_bib0032","first-page":"1","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weskler","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.xphs.2025.104064_bib0033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"10.1016\/j.xphs.2025.104064_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13070969","article-title":"Development of a cyclodextrin-based mucoadhesive-thermosensitive In situ gel for Clonazepam intranasal delivery","volume":"13","author":"Cirri","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.104064_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14227\/DT270120P22","article-title":"Comparison of dissolution profiles and apparent permeabilities of commercially available metformin hydrochloride tablets in Turkey","author":"Akdag","year":"2020","journal-title":"Dissolution Technol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104064_bib0036","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejpb.2005.08.010","article-title":"Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability","volume":"62","author":"Zerrouk","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0037","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1208\/s12248-014-9614-7","article-title":"Mechanism-based pharmacokinetic modeling to evaluate transporter-enzyme interplay in drug interactions and pharmacogenetics of glyburide","volume":"16","author":"Varma","year":"2014","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.xphs.2025.104064_bib0038","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.dmpk.2015.02.004","article-title":"Paroxetine decreased plasma exposure of glyburide partly via inhibiting intestinal absorption in rats","volume":"30","author":"Jiang","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.xphs.2025.104064_bib0039","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2006.05.004","article-title":"Biorelevant dissolution media as a predictive tool for glyburide a class II drug","volume":"29","author":"Wei","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104064_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12010079","article-title":"Comparison of various cell lines and three-dimensional mucociliary tissue model systems to estimate drug permeability using an In vitro transport study to predict nasal drug absorption in rats","volume":"12","author":"Furubayashi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2025.104064_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184122","article-title":"D-galactose-induced brain ageing model: A systematic review and meta-analysis on cognitive outcomes and oxidative stress indices","volume":"12","author":"Sadigh-Eteghad","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2025.104064_bib0042","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.brainresbull.2017.08.014","article-title":"Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse","volume":"134","author":"Wei","year":"2017","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.xphs.2025.104064_bib0043","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.physbeh.2015.11.016","article-title":"Protective effect of tetrahydropalmatine against d-galactose induced memory impairment in rat","volume":"154","author":"Qu","year":"2016","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.xphs.2025.104064_bib0044","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S106235902360455X","article-title":"Methylene blue attenuates impaired cognitive functions and reduces hippocampal a\u03b2 levels and oxidative stress in D-Galactose-induced Alzheimer\u2019s Disease Mouse model","volume":"51","author":"Kazkayasi","year":"2024","journal-title":"Biol Bull"},{"issue":"1","key":"10.1016\/j.xphs.2025.104064_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D\u2019Hooge","year":"2001","journal-title":"Brain Res Rev"},{"issue":"31","key":"10.1016\/j.xphs.2025.104064_bib0046","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.2174\/1381612819666131216114240","article-title":"The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia","volume":"20","author":"Rajagopal","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0047","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/bmc.3314","article-title":"Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS\/MS","volume":"29","author":"Zhang","year":"2015","journal-title":"Biomed Chromatogr"},{"issue":"10","key":"10.1016\/j.xphs.2025.104064_bib0048","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.2042-7158.2012.01515.x","article-title":"Long-term stability of quercetin nanocrystals prepared by different methods","volume":"64","author":"Kakran","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2025.104064_bib0049","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"Antidiabetic drugs restore abnormal transport of amyloid-\u03b2 across the blood\u2013brain barrier and memory impairment in db\/db mice","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharm"},{"key":"10.1016\/j.xphs.2025.104064_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.reth.2020.08.003","article-title":"Cryoprotective enhancing effect of very low concentration of trehalose on the functions of primary rat hepatocytes","volume":"15","author":"Yoshida","year":"2020","journal-title":"Regen Ther"},{"issue":"12","key":"10.1016\/j.xphs.2025.104064_bib0051","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/cbic.200600322","article-title":"Cryoprotection with L- and meso-trehalose: stereochemical implications","volume":"7","author":"Seo","year":"2006","journal-title":"Chem Bio Chem"},{"key":"10.1016\/j.xphs.2025.104064_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.887598","article-title":"Investigation of the uptake and transport of aspirin eugenol ester in the caco-2 cell model","volume":"13","author":"Tao","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104064_bib0053","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/brainsci3010215","article-title":"The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity","volume":"3","author":"Tosun","year":"2013","journal-title":"Brain Sci"},{"issue":"6","key":"10.1016\/j.xphs.2025.104064_bib0054","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/fcp.12796","article-title":"Glibenclamide promoted functional recovery following sciatic nerve injury in male Wistar rats","volume":"36","author":"Ferdowsi","year":"2022","journal-title":"Fundam Clin Pharmacol"},{"issue":"152","key":"10.1016\/j.xphs.2025.104064_bib0055","doi-asserted-by":"crossref","DOI":"10.3791\/60055","article-title":"Analysis of learning and memory ability in an Alzheimer's disease mouse model using the Morris water maze","author":"Tian","year":"2019","journal-title":"J Vis Exp"},{"issue":"53","key":"10.1016\/j.xphs.2025.104064_bib0056","doi-asserted-by":"crossref","DOI":"10.3791\/2920-v","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","author":"Bromley-Brits","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.xphs.2025.104064_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173416","article-title":"Glibenclamide modulates microglial function and attenuates a\u03b2 deposition in 5XFAD mice","volume":"884","author":"Ju","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.xphs.2025.104064_bib0058","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/14728222.2023.2240023","article-title":"The ATP-sensitive potassium channel: a therapeutic target for neurodegeneration?","volume":"27","author":"Xiao","year":"2023","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0059","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-2012-120151","article-title":"Novel object recognition as a facile behavior test for evaluating drug effects in A\u03b2PP\/PS1 Alzheimer's disease mouse model","volume":"31","author":"Zhang","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.xphs.2025.104064_bib0060","first-page":"7","article-title":"Alzheimer hastal\u0131\u011f\u0131n\u0131n patofizyolojisi\/the pathophysiology of Alzheimer's disease","volume":"5","author":"Elmac\u0131","year":"2012","journal-title":"Turkiye Klinikleri Neurol"},{"issue":"3, Supplement 2","key":"10.1016\/j.xphs.2025.104064_bib0061","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0002-9343(85)80010-3","article-title":"Pharmacokinetics of glyburide","volume":"79","author":"Pearson","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1016\/j.xphs.2025.104064_bib0062","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.xphs.2025.104064_bib0063","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/j.1875-9114.1985.tb03404.x","article-title":"Glyburide: a second-generation sulfonylurea hypoglycemic agent: history, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects","volume":"5","author":"Feldman","year":"1985","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0064","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1208\/s12248-014-9614-7","article-title":"Mechanism-based pharmacokinetic modeling to evaluate transporter-enzyme interplay in drug interactions and pharmacogenetics of glyburide","volume":"16","author":"Varma","year":"2014","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.104064_bib0065","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1208\/s12248-013-9514-2","article-title":"Effects of selected OATP and\/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide","volume":"15","author":"Tournier","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.104064_bib0066","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.brainresbull.2018.01.001","article-title":"ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression-and anxiety-related symptoms in a rat model of Alzheimer's disease","volume":"137","author":"Esmaeili","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.xphs.2025.104064_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112359","article-title":"Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease","volume":"379","author":"Esmaeili","year":"2020","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.xphs.2025.104064_bib0068","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2478\/jvetres-2021-0064","article-title":"Glibenclamide ameliorates the expression of neurotrophic factors in sevoflurane anaesthesia-induced oxidative stress and cognitive impairment in hippocampal neurons of old rats","volume":"65","author":"Ma","year":"2021","journal-title":"J Vet Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:53:20Z","timestamp":1773838400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022354925005180"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104064","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104064"}}